Floris Engelhardt

Co-founder & CEO at Kano Therapeutics

Floris Engelhardt has extensive experience in research and entrepreneurship, holding positions at various prestigious institutions such as Kano Therapeutics, University of Massachusetts Boston, Activate, Massachusetts Institute of Technology, and Technische Universität München. With a background in biochemistry and molecular biology, Floris has pursued higher education at Technical University of Munich, University of York, and Friedrich Schiller University Jena. More information can be found at http://bathebionano.org.

Links

Previous companies

TU München logo
Activate logo

Timeline

  • Co-founder & CEO

    March, 2022 - present

View in org chart